New tool for insertional mutagenesis in the mouse
Award amount
$99,510Program and phase
SBIR · Phase IAward year
2003Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INGENIOUS TARGETING LABORATORY INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- KLFLHV967JW4
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies
- Humanization of ACE2 and Associated Priming Proteases in New Mouse Models for Downstream Disease and Therapy Investigations of COVID-19
- Genetic Modification of the Rabbit for Development of Single Chain Antibodies
- Business Potential of a Novel Small Animal Model and its Single-Chain Antibodies
Research funding history
5 SBIR/STTR records share this UEI (2003–2022). Reported award amounts total $4,497,162. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services